How to buy Deciphera Pharmaceuticals LLC stock (DCPH)

Deciphera Pharmaceuticals LLC is a drug manufacturers - specialty & generic business based in the US. Deciphera Pharmaceuticals LLC shares (DCPH) are listed on the NASDAQ and all prices are listed in US Dollars. Deciphera Pharmaceuticals LLC employs 355 staff and has a trailing 12-month revenue of around $174.9 million.

Our top picks for where to buy Deciphera Pharmaceuticals LLC stock

Buy Deciphera Pharmaceuticals LLC stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Deciphera Pharmaceuticals LLC stock price (NASDAQ: DCPH)

Use our graph to track the performance of DCPH stocks over time.

Deciphera Pharmaceuticals LLC shares at a glance

• Key figures

Information last updated 2024-09-08.

52-week range	$13.25 - $25.61
50-day moving average more info button	$21.67
200-day moving average more info button	$15.94
Wall St. target price	$27.52
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-2.21

Is it a good time to buy Deciphera Pharmaceuticals LLC stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Deciphera Pharmaceuticals LLC financials

Revenue TTM	$174.9 million
Gross profit TTM	$-62,555,000
Return on assets TTM	-26.62%
Return on equity TTM	-50.37%
Profit margin	-108.87%
Book value	$3.85
Market Capitalization more info button	$2.2 billion

TTM: trailing 12 months

Deciphera Pharmaceuticals LLC share dividends

We're not expecting Deciphera Pharmaceuticals LLC to pay a dividend over the next 12 months.

Deciphera Pharmaceuticals LLC share price volatility

Over the last 12 months, Deciphera Pharmaceuticals LLC's shares have ranged in value from as little as $13.25 up to $25.61. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Deciphera Pharmaceuticals LLC's is 0.184. This would suggest that Deciphera Pharmaceuticals LLC's shares are less volatile than average (for this exchange).

Deciphera Pharmaceuticals LLC overview

Deciphera Pharmaceuticals, Inc. , a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. As of June 11, 2024, Deciphera Pharmaceuticals, Inc.

Frequently asked questions

null
What percentage of Deciphera Pharmaceuticals LLC is owned by insiders or institutions?
Currently 28.484% of Deciphera Pharmaceuticals LLC shares are held by insiders and 72.031% by institutions. How many people work for Deciphera Pharmaceuticals LLC?
Latest data suggests 355 work at Deciphera Pharmaceuticals LLC. When does the fiscal year end for Deciphera Pharmaceuticals LLC?
Deciphera Pharmaceuticals LLC's fiscal year ends in December. Where is Deciphera Pharmaceuticals LLC based?
Deciphera Pharmaceuticals LLC's address is: 200 Smith Street, Waltham, MA, United States, 02451 What is Deciphera Pharmaceuticals LLC's ISIN number?
Deciphera Pharmaceuticals LLC's international securities identification number is: US24344T1016 What is Deciphera Pharmaceuticals LLC's CUSIP number?
Deciphera Pharmaceuticals LLC's Committee on Uniform Securities Identification Procedures number is: 24344T101